SkinCeuticals Resveratrol B E — Advanced Nighttime Antioxidant Serum for Firm, Radiant, Youthful Skin

SkinCeuticals Resveratrol B E — Product Overview

SkinCeuticals Resveratrol B E is a nighttime antioxidant treatment containing a maximised concentration of resveratrol — a stilbene polyphenol derived from Polygonum cuspidatum (Japanese knotweed) — combined with baicalin (a flavone extracted from Scutellaria baicalensis) and alpha-tocopherol (vitamin E). The formulation targets the skin's circadian repair window during sleep to amplify cellular antioxidant activity through three complementary mechanisms: sirtuin-1 (SIRT1) enzyme pathway activation by resveratrol, broad-spectrum free radical scavenging by baicalin, and lipid-phase membrane antioxidant protection by alpha-tocopherol. This multi-pathway approach addresses oxidative damage from UV radiation, visible light, and particulate pollution accumulated during daytime exposure in Singapore's urban environment.

In a double-blind, placebo-controlled clinical study (n=30, 12 weeks), Resveratrol B E demonstrated statistically significant improvements in skin density, firmness, and surface radiance versus untreated control. Baicalin at 0.5% has been shown in independent in vitro and ex vivo studies to stabilise the resveratrol molecule against oxidative degradation and to act synergistically with resveratrol to enhance SIRT1 pathway activity beyond that achieved by either ingredient alone. The product is manufactured under L'Oréal's ISO 22716:2007-certified Good Manufacturing Practice standards and is notified as a cosmetic product under the Singapore Health Sciences Authority (HSA) Health Products Act (Cap. 122D), compliant with the ASEAN Cosmetic Directive.

Product Specifications

Clinical Indications and Aesthetic Applications

• Photoaged skin with fine lines and surface irregularity: Resveratrol's SIRT1 pathway activation supports nocturnal DNA repair and collagen synthesis; indicated as an adjunct to daytime photoprotection in patients with Fitzpatrick II–V photodamage presenting with dyschromia, rhytides, or loss of skin density.
• Post-procedure skin recovery: Suitable for use in the recovery phase following ablative laser resurfacing, medium-depth chemical peels, or microneedling once re-epithelialisation is complete; antioxidant load supports tissue remodelling and reduces post-inflammatory oxidative stress.
• Perimenopause-associated skin laxity and accelerated ageing: Resveratrol and alpha-tocopherol combination addresses accelerated oxidative damage and collagen degradation associated with oestrogen decline; clinical data support improvements in firmness and skin density relevant to this patient cohort.
• 24-hour antioxidant protocol in aesthetic clinic programmes: Designed as a nighttime complement to daytime vitamin C antioxidants (e.g., SkinCeuticals C E Ferulic, Phloretin CF) for comprehensive oxidative protection against UV, infrared, and air pollution insults in Singapore's high-UV equatorial climate.
• Patients on topical retinoid therapy requiring antioxidant support: The fragrance-free, paraben-free formulation is well tolerated alongside topical tretinoin or adapalene; may be alternated or layered nightly with minimal additive irritation risk.
• Longevity and cellular health programmes: Incorporated by functional medicine and integrative clinicians given resveratrol's established SIRT1 activator mechanism, complementary to oral NAD+ precursor supplementation targeting the same sirtuinpathway.

Frequently Asked Questions

Q: What is the mechanism of resveratrol in this topical formulation?
A: Resveratrol is a stilbene polyphenol that activates sirtuin deacetylase enzymes — specifically SIRT1 — which regulate oxidative stress response, DNA repair, and mitochondrial biogenesis at the cellular level. Applied topically at 1%, resveratrol penetrates to the viable epidermis and delivers antioxidant defence via both direct free radical scavenging and upregulation of endogenous antioxidant enzymes including superoxide dismutase and catalase. The baicalin co-formulated at 0.5% synergistically enhances SIRT1 activation and stabilises resveratrol against oxidative degradation.

Q: Can this product be used alongside prescription tretinoin or topical retinoids?
A: Yes. Resveratrol B E is applied post-cleansing in the evening; when co-prescribed with retinoids, it is typically applied before the retinoid, with a 1–2 minute absorption interval. The formulation's absence of fragrance, alcohol denat., and parabens reduces sensitisation risk in patients on active retinoid therapy. If significant retinoid-associated erythema or desquamation is present, clinician assessment should guide sequencing.

Q: How does Resveratrol B E differ from SkinCeuticals C E Ferulic?
A: SkinCeuticals C E Ferulic is a daytime antioxidant serum containing L-ascorbic acid (15%), alpha-tocopherol (1%), and ferulic acid (0.5%), optimised for photoprotective antioxidant defence under UV exposure and SPF. Resveratrol B E is formulated for nighttime use without photosensitive ascorbic acid, targeting the circadian repair phase. The two formulations address complementary time-of-day antioxidant demands and are prescribed together as morning and evening components of a 24-hour antioxidant protocol.

Q: Is Resveratrol B E suitable for Singapore's tropical climate and skin types?
A: Yes. The lightweight serum texture is appropriate for high-humidity, equatorial conditions and is non-comedogenic. It is compatible with the full range of Fitzpatrick phototypes commonly encountered in Singapore's multi-ethnic population. Storage at room temperature (24–27°C typical in Singapore) is within the product's stability specification; refrigeration is not required. Patients in Singapore experiencing high daily UV exposure (UV Index 11–14) particularly benefit from dual daytime and nighttime antioxidant therapy.

Q: How does EMIS supply SkinCeuticals Resveratrol B E to clinics?
A: EMIS Singapore supplies SkinCeuticals Resveratrol B E to dermatology clinics, aesthetic medical centres, and hospital pharmacy departments. Products are supplied as HSA-notified cosmetic products under the ASEAN Cosmetic Directive and Health Products Act (Cap. 122D). Bulk pricing, minimum order quantities, clinical protocol resources, and product training are available upon institutional enquiry via the EMIS procurement team.